Analysis of the key themes driving M&A activity reveals that big data accounted for seven medical devices deals announced in Q3 2024, worth a total value of $1.7m. The $1.5m minority acquisition of Guangdong Yinwei Decoding Biotechnology by Sino-Life Group and Zhongke Xunda Biotechnology (Shenzhen) was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, big data-related deal activity decreased by 100% in Q3 2024 compared with the previous quarter’s total of $4.2bn. Related deal volume decreased by 13% in Q3 2024 versus the previous quarter and was 40% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in 9M 2024 were Citigroup; Earlybird Venture Capital; lego corporate finance with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in 9M 2024 were Eversheds Sutherland (International); Greenberg Traurig; Kirkland & Ellis with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.